Back to today’s briefing

Story perspectives

Cancer Genetic Testing Market to Surge to $19.3 Billion

2/28/2025

47 8

Summary

Story summary

The cancer-focused genetic testing market is set to soar from $8.47 billion in 2024 to an impressive $19.3 billion by 2034, fueled by a robust 8.6% annual growth rate. Innovations in precision medicine, a rising need for early detection, and plummeting testing costs are propelling this growth, with the U.S. at the forefront, trailed by the UK, India, and China.

1 of 1

Story summary

The cancer-focused genetic testing market is set to soar from $8.47 billion in 2024 to an impressive $19.3 billion by 2034, fueled by a robust 8.6% annual growth rate. Innovations in precision medicine, a rising need for early detection, and plummeting testing costs are propelling this growth, with the U.S. at the forefront, trailed by the UK, India, and China.